Aclarion, Inc. (ACON) to Showcase NOCISCAN’s Impact on Spine Surgery at 2025 Spine Summit
We recently compiled a list of the Top 8 Must-See AI News Updates Investors Probably Missed. In this article, we are going to ...
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the 2025 Spine Summit
Dr. Nicholas Theodore to highlight NOCISCAN capabilities combining MR Spectroscopy and augmented intelligence (AI) NOCISCAN is an innovative decision support tool that helps physicians personalize ...
Aclarion Wins Patent, Shares Eke Up
Aclarion, Inc. (NASDAQ: ACON) shares cleared breakeven Tuesday, as the health-care technology company announced it has received a Notice of Allowance from the United States Patent and Trademark Office ...
Aclarion secures patent for infection, pain biomarker detection
BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ:ACON, ACONW), a healthcare technology company, announced today it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent ...
Taiwan News14d
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
Feb. 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented ...
FOX59 News14d
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while reducing costs for chronic low back pain Nociscan aims to become the gold standard in ...